NCT01797055View on ClinicalTrials.gov

Apotransferrin in Atransferrinemia

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

March 31, 2022

Study Completion Date

January 31, 2028

Conditions
Congenital Atransferrinemia
Interventions
DRUG

Human apotransferrin

intravenous infusion

Trial Locations (3)

20900

AO San Gerardo, Monza

Unknown

Klinikum Aschaffenburg, Aschaffenburg

Vall d'Hebron Hospital, Barcelona

Sponsors
All Listed Sponsors
lead

Prothya Biosolutions

INDUSTRY